The Effect of Alendronate on Fracture-Related Healthcare Utilization and Costs: The Fracture Intervention Trial

Overview of attention for article published in Osteoporosis International, September 2001

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

policy: 2 policy sources

guideline: 1 clinical guideline source

Readers on

mendeley: 45 Mendeley

So far, Altmetric has seen 3 policy documents that reference this research output.

Какие фактические данные существуют в отношении профилактики остеопороза и скрининга с целью выявления этого заболевания?

Cited by World Health Organization (WHO) on 08 Nov 2022

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

What evidence is there for the prevention and screening of osteoporosis?

Cited by World Health Organization (WHO) on 08 Nov 2022

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

Bisphosphonate Drugs for the Treatment of Osteoporosis in Post-Menopausal Women - Drugs for the Treatment and Prevention of Osteoporosis in Postmenopausal Wome

Cited by Canadian Agency for Drugs and Technologies in Health (CADTH) on 01 Jun 2021

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.